Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. (Source: http://en.wikipedia.org/wiki/Indacaterol).
MedKoo Cat#: 314224
Name: Indacaterol
CAS#: 312753-06-3 (free base)
Chemical Formula: C24H28N2O3
Exact Mass: 392.2100
Molecular Weight: 392.50
Elemental Analysis: C, 73.44; H, 7.19; N, 7.14; O, 12.23
| Solvent | mg/mL | mM | |
|---|---|---|---|
| Solubility | |||
| DMF:PBS (pH 7.2) (1:3) | 0.3 | 0.64 | |
| DMSO | 43.2 | 109.98 | |
| Ethanol | 10.5 | 26.75 |
The following data is based on the product molecular weight 392.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
